FMP

FMP

Enter

ALTER.PA - Theradiag SA

Financial Summary of Theradiag SA(ALTER.PA), Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunit

photo-url-https://financialmodelingprep.com/image-stock/ALTER.PA.png

Theradiag SA

ALTER.PA

EURONEXT

Inactive Equity

Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides instrumentation, including Theralis that integrates multiplex FIDIS immunofluorescence and ELISA; Theralis µ, a solution for medium sized laboratories; and FIDIS platform used in laboratory for analysis. In addition, it offers therapeutic drug monitoring services for treatment of chronic inflammatory diseases; and LISA tracker, a tool for monitoring of biotherapies, as well as Elisa and rapid tests for SARS-CoV 2 serology. The company was founded in 1986 and is based in Marne La Vallee, France.

1.26 EUR

-0.065 (-5.16%)

About

ceo

Mr. Simon Daviere

sector

Healthcare

industry

Medical - Devices

website

https://www.theradiag.com

exchange

EURONEXT

Description

Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides instrumentation, including Theralis that integrates multiplex FIDIS immunofluorescence and ELISA; Theralis µ, a solution for medium sized laboratories; and FIDIS platform used in laboratory for analysis. In addition, it offers therapeutic drug monitoring services for treatment of chronic inflammatory diseases; and LI...

CIK

N/A

ISIN

FR0004197747

CUSIP

F1022P100

Address

14 rue Ambroise Croizat

Phone

33 1 64 62 10 12

Country

FR

Employee

60

IPO Date

Dec 11, 2012

Summary

CIK

-

Exchange

EURONEXT

Industry

Medical - Devices

Sector

Healthcare

CUSIP

F1022P100

ISIN

FR0004197747

Country

FR

Price

1.26

Beta

-0.27

Volume Avg.

4.07k

Market Cap

17.29M

Shares

-

52-Week

1.18-2.39

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

42

P/B

-

Website

https://www.theradiag.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ALTER.PA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep